BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16127182)

  • 1. Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease.
    Kato R; Momiyama Y; Ohmori R; Taniguchi H; Nakamura H; Ohsuzu F
    Circ J; 2005 Sep; 69(9):1035-40. PubMed ID: 16127182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report.
    Saita E; Miura K; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):49-52. PubMed ID: 27789477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.
    Ibe S; Kishimoto Y; Niki H; Saita E; Umei T; Miura K; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    Heart Vessels; 2019 Jun; 34(6):965-970. PubMed ID: 30599062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
    Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
    Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina.
    Momiyama Y; Ohmori R; Tanaka N; Kato R; Taniguchi H; Adachi T; Nakamura H; Ohsuzu F
    Atherosclerosis; 2010 Mar; 209(1):206-10. PubMed ID: 19674746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.
    Ohmori R; Momiyama Y; Taniguchi H; Takahashi R; Kusuhara M; Nakamura H; Ohsuzu F
    Atherosclerosis; 2003 Oct; 170(2):333-7. PubMed ID: 14612215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
    Kalela A; Koivu TA; Sisto T; Kanervisto J; Höyhtyä M; Sillanaukee P; Lehtimäki T; Nikkari ST
    Scand J Clin Lab Invest; 2002; 62(5):337-42. PubMed ID: 12387578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
    Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
    Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
    Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Plasma Sestrin2 Levels and the Presence and Severity of Coronary Artery Disease.
    Kishimoto Y; Aoyama M; Saita E; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    Dis Markers; 2020; 2020():7439574. PubMed ID: 32670435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Plasma Levels of Soluble Talin-1 in Patients with Coronary Artery Disease.
    Aoyama M; Kishimoto Y; Saita E; Ikegami Y; Ohmori R; Nakamura M; Kondo K; Momiyama Y
    Dis Markers; 2020; 2020():2479830. PubMed ID: 32566035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Plasma Follistatin-like Protein 1 Levels and the Presence and Severity of Coronary Artery Disease.
    Yamazaki Y; Kishimoto Y; Saita E; Aoyama M; Ikegami Y; Ohmori R; Tanimoto K; Kondo K; Momiyama Y
    Int Heart J; 2021; 62(6):1207-1212. PubMed ID: 34853217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease.
    Hwang JJ; Yang WS; Chiang FT; Chen MF; Lin HJ; Huang PJ; Hsu SH; Lai SK; Wu YW
    Atherosclerosis; 2009 May; 204(1):293-7. PubMed ID: 18823886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease.
    Wang Z; Ye D; Ye J; Wang M; Liu J; Jiang H; Xu Y; Zhang J; Chen J; Wan J
    Dis Markers; 2019; 2019():6129748. PubMed ID: 31929842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Plasma Levels of Legumain in Patients with Complex Coronary Lesions.
    Umei TC; Kishimoto Y; Aoyama M; Saita E; Niki H; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2020 Jul; 27(7):711-717. PubMed ID: 31735728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between abdominal aortic plaque and coronary artery disease.
    Li W; Luo S; Luo J; Liu Y; Huang W; Chen J
    Clin Interv Aging; 2016; 11():683-8. PubMed ID: 27279740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.